4D Molecular Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: 4D Molecular Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: 4D Molecular Therapeutics Inc
Rating: 1.79258325
Author: Trendlyne DVM scores

about

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic a...

7.96 -0.13 (-1.61%)

35.49% Fall from 52W High

539.7K

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

12.8 / 100

Technically Neutral

58.9 / 100

1Yr Price target upside is 316%

9 analysts

4D Molecular Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

4D Molecular Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic a...

35.49% Fall from 52W High

SWOT Analysis

4D Molecular Therapeutics Inc Live Price Chart